Number of the records: 1  

neoplázia endokrinná mnohopočetná, typ 2a

  1. SYSd018813
    LBL
      
    00000cz--a2200000o--4500
    005
      
    20250606213413.6
    008
      
    940523|||anznnbabn-----------|-a|a------
    040
      
    $b slo $a DNLM $d BA006
    065
      
    $a C04.588.322.400.505
    065
      
    $a C04.651.600.505
    065
      
    $a C04.700.630.505
    065
      
    $a C16.320.700.630.505
    065
      
    $a C19.344.400.505
    066
      
    $a 01 $c 03
    150
      
    $a neoplázia endokrinná mnohopočetná, typ 2a $x BL $x BS $x CF $x CH $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SC $x SU $x TH $x UL $x UR $x VE $x VI $2 slo
    450
      
    $w v $a MEN 2 $2 eng
    450
      
    $w v $a MEN 2a $2 eng
    450
      
    $w v $a Neoplasia, Multiple Endocrine Type 2a $2 eng
    450
      
    $w v $a Neoplasms, Multiple Endocrine Type 2a $2 eng
    450
      
    $w v $a Sipple Syndrome $2 eng
    450
      
    $w v $a MEN2a $2 slo
    450
      
    $w v $a MEN 2 $2 slo
    450
      
    $w v $a MEN 2a $2 slo
    450
      
    $w v $a nádory endokrinné mnohopočetné, typ 2a $2 slo
    450
      
    $w v $a Sippleov syndróm $2 slo
    550
      
    $7 sllk_us_auth*d010673 $Y Pheochromocytoma $w b $a feochromocytóm
    550
      
    $7 sllk_us_auth*d018276 $Y Carcinoma, Medullary $w b $a karcinóm medulárny
    665
      
    $a 95; MEA II, MEN II, & SIPPLE SYNDROME were see NEOPLASMS, MULTIPLE ENDOCRINE 1983-94 $2 eng
    665
      
    $a Multiple Endocrine Neoplasia (1966-1994) $2 eng
    680
    9-
    $i A form of multiple endocrine neoplasia characterized by the presence of medullary carcinoma (CARCINOMA, MEDULLARY) of the THYROID GLAND, and usually with the co-occurrence of PHEOCHROMOCYTOMA, producing CALCITONIN and ADRENALINE, respectively. Less frequently, it can occur with hyperplasia or adenoma of the PARATHYROID GLANDS. This disease is due to gain-of-function mutations of the MEN2 gene on CHROMOSOME 10 (Locus: 10q11.2), also known as the RET proto-oncogene that encodes a RECEPTOR PROTEIN-TYROSINE KINASE. It is an autosomal dominant inherited disease. $2 eng
    680
      
    $a coordinate IM with specific endocrine/neoplasm pre-coordinates (IM) + specific histological type (IM) if pertinent $2 eng
    750
    -2
    $a Multiple Endocrine Neoplasia Type 2a $2 eng
    980
      
    $x M
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.